ACTIVE SUBSTANCE / INN

DULOXETINE

Brand name(s): Yentreve, Duloxetine Lilly, Duloxetine Boehringer Ingelheim, Duloxetine Zentiva, Ariclaim, Duloxetine Sandoz, Duloxetine Viatris (previously Duloxetine Mylan), Cymbalta, Nodetrip (previously Xeristar)
EMA LISTED
APPLICATION WITHDRAWN
WITHDRAWN
AUTHORISED
Neuralgia;Depressive Disorder, Major;Anxiety Disorders;Diabe…
Diabetic Neuropathies
ACTIVE SUBSTANCE
Duloxetine
REGULATORS
EMA
SPONSORS / MAH
Esteve Pharmaceuticals, S.A., Sandoz GmbH, Viatris Limited
TOTAL APPLICATIONS
9
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Duloxetine Viatris (previously Duloxetine Mylan)Viatris LimitedAuthorised19/06/2015Neuralgia;Diabetic Neuropathies;Depressive Disorder, Major;Anxiety Disorders
Duloxetine ZentivaZentiva, k.s.Authorised20/08/2015Neuralgia;Depressive Disorder, Major;Anxiety Disorders;Diabetes Mellitus
Duloxetine LillyEli Lilly Nederland B.V.Authorised08/12/2014Neuralgia;Diabetic Neuropathies;Depressive Disorder, Major
CymbaltaEli Lilly Nederland B.V.Authorised17/12/2004Anxiety Disorders;Diabetic Neuropathies;Depressive Disorder, Major
YentreveEli Lilly Nederland B.V.Authorised11/08/2004Urinary Incontinence, Stress
Nodetrip (previously Xeristar)Esteve Pharmaceuticals, S.A.Withdrawn17/12/2004Anxiety Disorders;Depressive Disorder, Major;Diabetic Neuropathies
AriclaimEli Lilly Nederland B.V.Withdrawn11/08/2004Diabetic Neuropathies
Duloxetine SandozSandoz GmbHApplication withdrawnAnxiety Disorders;Neuralgia;Diabetes Mellitus;Depressive Disorder, Major
Duloxetine Boehringer IngelheimBoehringer Ingelheim International GmbHWithdrawn08/10/2008Diabetic Neuropathies

FULL INTELLIGENCE ON DULOXETINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →